MiMedx Share Price

MiMedx Share Price

NASDAQ: MDXG | Small Cap | Healthcare
$3.06
-$0.04 (-1.45%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

MiMedx Stock Performance

Open
$3.09
Prev. Close
$3.10
Circuit Range
N/A
Day Range
$3.03 - $3.13
Year Range
$3.03 - $7.44
Volume
1,07,520
Average Traded
$3.07

MiMedx Share Price Today

As of 22 November 2026, MiMedx Group, Inc's share price is $3.06. The stock opened at $3.09, compared to its previous close of $3.10. During today's trading session, MiMedx Group, Inc's share price traded between $3.03 and $3.13, with an average price of $3.08. Over the past 52 weeks, the stock has recorded a high of $7.44 and a low of $3.03. In terms of performance, MiMedx Group, Inc's share price has declined by 17.07% over the last six months and is down 55.49% on a year-on-year basis.

MiMedx Share Price Chart

Line chart of the MiMedx price trend over the selected period. The price fell overall, ranging from 3.03 to 3.13, ending at 3.06.
$3.03$3.13
L
Show Current Price
H

MiMedx Stock Fundamentals & Key Indicators

Market Cap
$452.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.37%
EPS (TTM)
$-0.13
Revenue (TTM)
$418.63B
Return On Equity (TTM)
-9.09%
Profit Margin
11.60%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-157.14%

MiMedx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$118.10$58.99$64.36$62.28
Net Profit$15.19-$10.86-$14.84-$8.68
Net Profit Margin12.86%-18.41%-23.06%-13.94%
Income ChangeN/A-171.49%-36.65%41.51%

MiMedx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$267.84$321.48$348.88$418.63
Net Profit-$30.20$58.23$42.42$48.58
Net Profit Margin-11.28%18.11%12.16%11.60%
Income ChangeN/A292.81%-27.15%14.52%

MiMedx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets65.1872.0374.7937.23
Current Assets277.47191.89164.26134.2
Total Assets342.65263.92239.05171.43
Non Current Liabilities21.8425.2151.6754.85
Current Liabilities64.2745.644.6642.08
Total Liabilities86.1170.8196.3396.92
Shareholders' Equity256.55193.11142.72-17.99

MiMedx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating74.066.226.78-17.89
Investing-6.89-9.58-2.16-2.66
Financing-5.41-34.2-8.57-0.58

About MiMedx

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

MiMedx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.87
$3.06
-21.57%
Oct 2026
$4.67
$3.90
-16.33%
Sep 2026
$4.56
$4.66
+2.99%
Aug 2026
$4.32
$4.52
+9.31%
Jul 2026
$3.92
$4.13
+7.40%
Jun 2026
$3.61
$3.85
+4.34%
May 2026
$3.48
$3.69
+9.66%
Apr 2026
$3.99
$3.37
-14.81%
Mar 2026
$4.75
$3.95
-19.39%
Feb 2026
$5.09
$4.90
-4.30%
Jan 2026
$6.71
$5.12
-24.32%
Dec 2025
$6.87
$6.76
-1.60%

MiMedx Share Price FAQs